Bittersweet China
14/09/23 -"China has been and will be a growth market, and also when it comes to medtech. On the other hand, the Chinese government aims to root out deep-seated corruption. We have a strong belief that ..."
Pages
70
Language
English
Published on
14/09/23
You may also be interested by these reports :
12/03/26
We have revised our 2025 figures downward as actuals came in weaker than expected, starting with a 3.5% miss on the top line. We were overly ...
05/03/26
Elekta’s Q3 profitability exceeded consensus expectations. Organic sales growth was recorded in EMEA and APAC, while the Americas exhibited weakness. ...
05/03/26
Amplifon reported another quarterly performance miss, with both sales and profitability falling short of the company-compiled consensus. Although the ...
04/03/26
We appreciate Clariane’s stronger-than-expected deleveraging and consider the 2026 targets easily achievable. However, the thin but consensus-beating ...